Bhuvaneswari Pharmach Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 31-12-2024
- Paid Up Capital ₹ 1.33 Cr
as on 31-12-2024
- Company Age 41 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.01 M
as on 31-12-2024
- Satisfied Charges ₹ 2.26 Cr
as on 31-12-2024
- Revenue -29.03%
(FY 2024)
- Profit -96.25%
(FY 2024)
- Ebitda 65.34%
(FY 2024)
- Net Worth 0.27%
(FY 2024)
- Total Assets -6.84%
(FY 2024)
About Bhuvaneswari Pharmach
The Company is engaged in the Machinery And Equipment Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.33 Cr.
The company currently has active open charges totaling ₹2.01 M. The company has closed loans amounting to ₹2.26 Cr, as per Ministry of Corporate Affairs (MCA) records.
Subha Devarajan and Sumathi Santhanam serve as directors at the Company.
- CIN/LLPIN
U93090TN1983PTC010322
- Company No.
010322
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Sep 1983
- Date of AGM
05 Jun 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Kanchipuram, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Bhuvaneswari Pharmach Private Limited offer?
Bhuvaneswari Pharmach Private Limited offers a wide range of products and services, including Industrial Mixers & Homogenizers, Batch Mixers, Industrial Mixers, Powder Mixers, Milling & Grinding Tools, Grinding Mill, Pulverizers, Ribbon Blender, Dryers & Evaporators, Vacuum Dryers.
Who are the key members and board of directors at Bhuvaneswari Pharmach?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Subha Devarajan  | Whole-Time Director | 25-Aug-2014 | Current |
| Sumathi Santhanam | Director | 28-Sep-2019 | Current |
Financial Performance of Bhuvaneswari Pharmach.
Bhuvaneswari Pharmach Private Limited, for the financial year ended 2024, experienced significant reduction in revenue, with a 29.03% decrease. The company also saw a substantial fall in profitability, with a 96.25% decrease in profit. The company's net worth moved up by a moderate rise of 0.27%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bhuvaneswari Pharmach?
In 2024, Bhuvaneswari Pharmach had a public holding of 17.89%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Dhandapani Finance Ltd. Creation Date: 13 Dec 1999 | ₹0.12 M | Open |
Dhandapani Finance Ltd. Creation Date: 28 Jun 1997 | ₹0.61 M | Open |
The Tamil Nadu Industrial Investment Corporation Ltd. Creation Date: 30 Nov 1989 | ₹1.09 M | Open |
How Many Employees Work at Bhuvaneswari Pharmach?
Bhuvaneswari Pharmach has a workforce of 11 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bhuvaneswari Pharmach, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bhuvaneswari Pharmach's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
